HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yongmei Xie Selected Research

lobaplatin

12/2019Corrigendum to "Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro" [Biomed. Pharmacother. 69 (2015) 402-408].
10/2016Lobaplatin induces BGC-823 human gastric carcinoma cell apoptosis via ROS- mitochondrial apoptotic pathway and impairs cell migration and invasion.
2/2015Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yongmei Xie Research Topics

Disease

21Neoplasms (Cancer)
06/2022 - 09/2012
9Neoplasm Metastasis (Metastasis)
06/2022 - 09/2012
6Melanoma (Melanoma, Malignant)
06/2022 - 02/2015
5Carcinoma (Carcinomatosis)
07/2018 - 09/2012
3Breast Neoplasms (Breast Cancer)
01/2021 - 02/2014
3Ovarian Neoplasms (Ovarian Cancer)
12/2015 - 05/2013
2Pulmonary Fibrosis (Fibrosing Alveolitis)
02/2022 - 10/2020
2Infections
10/2021 - 02/2018
2Papillary Thyroid Cancer
01/2021 - 08/2017
2Colorectal Neoplasms (Colorectal Cancer)
09/2019 - 02/2018
2Hypoxia (Hypoxemia)
07/2018 - 04/2018
1Diabetic Nephropathies (Diabetic Nephropathy)
02/2022
1Cognitive Dysfunction
01/2022
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022
1Carcinogenesis
01/2021
1Cicatrix (Scar)
11/2020
1Osteosarcoma (Osteogenic Sarcoma)
10/2019
1Drug-Related Side Effects and Adverse Reactions
09/2019
1Pathologic Processes
01/2019
1Experimental Melanoma
07/2018
1Sclerosis
07/2018
1Tuberculosis (Tuberculoses)
07/2018
1Tuberous Sclerosis (Bourneville's Disease)
07/2018
1Inborn Errors Metabolism (Inborn Errors of Metabolism)
02/2018
1Epilepsy (Aura)
02/2018
1Encephalitis (Encephalitis, Rasmussen)
02/2018
1Autoimmune Diseases of the Nervous System
02/2018
1Hyperargininemia
02/2018
1Growth Disorders
02/2018
1Colonic Neoplasms (Colon Cancer)
02/2018
1Cerebral Palsy (Spastic Diplegia)
02/2018
1Toxoplasmosis
02/2018
1Peripheral Nervous System Diseases (PNS Diseases)
02/2018
1Pain (Aches)
01/2018
1Gout
01/2018

Drug/Important Bio-Agent (IBA)

12Pharmaceutical PreparationsIBA
02/2022 - 01/2014
4nifuroxazide (Akabar)IBA
06/2022 - 02/2016
4Proteins (Proteins, Gene)FDA Link
10/2020 - 01/2014
4Biological ProductsIBA
01/2019 - 07/2015
3Matrix Metalloproteinases (MMPs)IBA
11/2020 - 02/2016
3lobaplatinIBA
12/2019 - 02/2015
3Caspase 3 (Caspase-3)IBA
09/2019 - 09/2017
3methoxy poly(ethylene glycol-co-epsilon-caprolactone)IBA
01/2019 - 09/2012
3MicellesIBA
02/2018 - 09/2012
2Bleomycin (Blenoxane)FDA LinkGeneric
02/2022 - 10/2020
2Urea (Carbamide)FDA LinkGeneric
10/2021 - 02/2018
2Biomarkers (Surrogate Marker)IBA
07/2021 - 01/2021
2Messenger RNA (mRNA)IBA
01/2021 - 01/2014
2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2021 - 01/2019
2Phosphotransferases (Kinase)IBA
11/2019 - 01/2019
2hinokiflavoneIBA
09/2019 - 07/2018
2monomethoxypolyethylene glycol (MPEG)IBA
02/2018 - 05/2013
2Irinotecan (Camptosar)FDA LinkGeneric
02/2018 - 12/2015
2Trastuzumab (Herceptin)FDA Link
12/2015 - 09/2014
2Surface-Active Agents (Surfactants)IBA
02/2015 - 09/2012
1Therapeutic UsesIBA
02/2022
1Hydroxyproline (4 Hydroxyproline)IBA
02/2022
1ErythropoietinFDA Link
01/2022
1peoniflorinIBA
01/2022
1IgYIBA
10/2021
1NitroreductasesIBA
07/2021
1Fluorescent Dyes (Fluorescent Probes)IBA
07/2021
1Long Noncoding RNAIBA
01/2021
1tetramethylpyrazineIBA
01/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1ConnexinsIBA
11/2020
1CollagenIBA
11/2020
1Connexin 43 (Connexin43)IBA
11/2020
1snake venom protein C activatorIBA
10/2020
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
10/2020
1Chimeric Antigen ReceptorsIBA
10/2020
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
10/2020
1cryptotanshinoneIBA
10/2020
1Adenosine Monophosphate (AMP)IBA
11/2019
1Adenosine Triphosphate (ATP)IBA
11/2019
1Glucose (Dextrose)FDA LinkGeneric
11/2019
1Anti-Bacterial Agents (Antibiotics)IBA
10/2019
1Antineoplastic Agents (Antineoplastics)IBA
09/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2019
1Eosine Yellowish-(YS) (Eosin)IBA
09/2019
1Hematoxylin (Haematoxylon)IBA
09/2019
1pectolinarigeninIBA
01/2019
1mangostinIBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
07/2018
1trans-sodium crocetinate (crocetin)IBA
07/2018
1Dihydrotachysterol (AT 10)IBA
02/2018
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
02/2018
1N-Methylaspartate (NMDA)IBA
02/2018
1Growth Hormone (Somatotropin)IBA
02/2018
1Topoisomerase InhibitorsIBA
02/2018
1Azithromycin (Zithromax)FDA LinkGeneric
02/2018
1ProdrugsIBA
02/2018
1LigandsIBA
01/2018
1AlkaloidsIBA
01/2018

Therapy/Procedure

12Therapeutics
01/2019 - 09/2012
3Drug Therapy (Chemotherapy)
02/2018 - 03/2013
2Intraperitoneal Injections
02/2022 - 09/2014
2Immunotherapy
10/2021 - 10/2020
2Precision Medicine
07/2018 - 04/2018
1Ligation
07/2018